Log In
BCIQ
Print this Print this
 

HER2osome

  Manage Alerts
Collapse Summary General Information
Company Aethlon Medical Inc.
DescriptionDevice which inhibits breast cancer progression by reducing breast cancer exosomes and HER2 protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Other device
Latest Stage of DevelopmentDiscovery
Standard IndicationAdjunct
Indication DetailsAdjunct to breast cancer treatment
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today